Abstract: The present invention includes methods and compositions for treating a transplant recipient by administration of a CB2 receptor agonist either alone or in combination with one or more active pharmaceutical ingredients to block the rejection of foreign tissue and prolong grafted organs, tissues and cells.
Type:
Grant
Filed:
August 17, 2012
Date of Patent:
January 2, 2018
Assignee:
TEMPLE UNIVERSITY OFFICE OF TECHNOLOGY TRANSFER
Inventors:
Toby K. Eisenstein, Rebecca R. Hartzell, Martin W. Alder, Joseph J. Meissier